Literature DB >> 30108864

Characterization and lymphocyte proliferation activity of an oligosaccharide degraded from Astragalus polysaccharide.

Zhen-Yuan Zhu1,2, Jin-Yu Zhang1, Fei Liu1, Ling Chen1, Li-Jing Chen3, Yun Tang1.   

Abstract

An Astragalus oligosaccharide (AOS) degraded from Astragalus polysaccharide (APS) and purified by membrane dialysis and silicon gel chromatography is studied in this paper. The structural features of AOS were investigated by a combination of chemical and instrumental analysis, such as monosaccharide analysis, periodate oxidation-Smith degradation, methylation analysis, electrospray ionization mass spectrometry (ESI-MS), Fourier transform infrared (FT-IR) spectrometry and nuclear magnetic resonance (NMR). The results indicated that AOS is an octasaccharide that consists of (3→)-linked-Rha, (1→3)-linked-Rha, (1→3,4)-linked-Araf, (1→3)-linked-Gal, terminal-linked-Gal and terminal-linked-Glc. The effects of AOS on cyclophosphamide-induced immunosuppression were determined by various studies, such as the proliferation of nucleated marrow, red blood cell (RBC) and white blood cell (WBC) populations, growth of the spleen and thymus, and increases in hemoglobin (HGB) concentration and granulocyte-macrophage colony stimulating factor (GM-CSF) level. The results indicated that AOS can restore cyclophosphamide-induced immunosuppression by stimulating the secretion of GM-CSF, which promoted the differentiation of progenitor cells after proliferation.

Entities:  

Year:  2017        PMID: 30108864      PMCID: PMC6071930          DOI: 10.1039/c7md00148g

Source DB:  PubMed          Journal:  Medchemcomm        ISSN: 2040-2503            Impact factor:   3.597


  37 in total

Review 1.  Prebiotic effects: metabolic and health benefits.

Authors:  Marcel Roberfroid; Glenn R Gibson; Lesley Hoyles; Anne L McCartney; Robert Rastall; Ian Rowland; Danielle Wolvers; Bernhard Watzl; Hania Szajewska; Bernd Stahl; Francisco Guarner; Frederique Respondek; Kevin Whelan; Veronique Coxam; Marie-Jeanne Davicco; Laurent Léotoing; Yohann Wittrant; Nathalie M Delzenne; Patrice D Cani; Audrey M Neyrinck; Agnes Meheust
Journal:  Br J Nutr       Date:  2010-08       Impact factor: 3.718

2.  Structural characterization and antioxidant activity in vitro of polysaccharides from angelica and astragalus.

Authors:  Xiuying Pu; Xiaolong Ma; Lu Liu; Jing Ren; Haibing Li; Xiaoyue Li; Shuang Yu; Weijie Zhang; Wenbo Fan
Journal:  Carbohydr Polym       Date:  2015-10-19       Impact factor: 9.381

3.  Myeloid growth factors. Clinical practice guidelines in oncology.

Authors:  Jeffrey Crawford; Betsy Althaus; James Armitage; Lodovico Balducci; Charles Bennett; Douglas W Blayney; Spero R Cataland; David C Dale; George D Demetri; Harry P Erba; James Foran; Alison G Freifeld; Mark L Heaney; Sally Htoy; Dwight D Kloth; Gary H Lyman; Wells A Messersmith; Laura Boehnke Michaud; Sarah C Miyata; Amy Robbins; Martin S Tallman; Saroj Vadhan-Raj; Peter Westervelt; Michael K Wong
Journal:  J Natl Compr Canc Netw       Date:  2007-02       Impact factor: 11.908

Review 4.  Evidence-based benefits of specific mixtures of non-digestible oligosaccharides on the immune system.

Authors:  Alma J Nauta; Johan Garssen
Journal:  Carbohydr Polym       Date:  2012-02-19       Impact factor: 9.381

5.  Effects of selenizing angelica polysaccharide and selenizing garlic polysaccharide on immune function of murine peritoneal macrophage.

Authors:  Zhenzhen Gao; Kuanhui Liu; Weijun Tian; Hongchao Wang; Zhenguang Liu; Youying Li; Entao Li; Cui Liu; Xiuping Li; Ranran Hou; Chanjuan Yue; Deyun Wang; Yuanliang Hu
Journal:  Int Immunopharmacol       Date:  2015-05-08       Impact factor: 4.932

6.  Effect of Astragalus polysaccharides on expression of TNF-α, IL-1β and NFATc4 in a rat model of experimental colitis.

Authors:  Min Yang; Huan-Bing Lin; Sitang Gong; Pei-Yu Chen; Lan-Lan Geng; Yong-Mei Zeng; Ding-You Li
Journal:  Cytokine       Date:  2014-08-15       Impact factor: 3.861

Review 7.  Botanical polysaccharides: macrophage immunomodulation and therapeutic potential.

Authors:  Igor A Schepetkin; Mark T Quinn
Journal:  Int Immunopharmacol       Date:  2005-11-10       Impact factor: 4.932

8.  Impact of five prophylactic filgrastim schedules on hematologic toxicity in early breast cancer patients treated with epirubicin and cyclophosphamide.

Authors:  Paola Papaldo; Massimo Lopez; Paolo Marolla; Enrico Cortesi; Mauro Antimi; Edmondo Terzoli; Patrizia Vici; Carlo Barone; Gianluigi Ferretti; Serena Di Cosimo; Paolo Carlini; Cecilia Nisticò; Francesca Conti; Luigi Di Lauro; Claudio Botti; Franco Di Filippo; Alessandra Fabi; Diana Giannarelli; Federico Calabresi
Journal:  J Clin Oncol       Date:  2005-08-29       Impact factor: 44.544

9.  Incidence and predictors of low chemotherapy dose-intensity in aggressive non-Hodgkin's lymphoma: a nationwide study.

Authors:  Gary H Lyman; David C Dale; Jonathan Friedberg; Jeffrey Crawford; Richard I Fisher
Journal:  J Clin Oncol       Date:  2004-09-20       Impact factor: 44.544

View more
  3 in total

Review 1.  The Function of Natural Polysaccharides in the Treatment of Ulcerative Colitis.

Authors:  Yafei Guo; Yang Li; Qiang Cao; Leilei Ye; Junmei Wang; Mei Guo
Journal:  Front Pharmacol       Date:  2022-07-04       Impact factor: 5.988

Review 2.  Polysaccharide-based nanomedicines for cancer immunotherapy: A review.

Authors:  Yujun Zeng; Yufan Xiang; Ruilong Sheng; Helena Tomás; João Rodrigues; Zhongwei Gu; Hu Zhang; Qiyong Gong; Kui Luo
Journal:  Bioact Mater       Date:  2021-03-18

3.  Astragalus Polysaccharides Enhance the Immune Response to OVA Antigen in BALB/c Mice.

Authors:  Yumei Zhou; Yuhan Zong; Zihao Liu; Haihong Zhao; Xiaoshan Zhao; Ji Wang
Journal:  Biomed Res Int       Date:  2021-06-28       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.